Manufacturing

Dec 11, 2017
By BioPharm International Editors
FDA has accepted for review Eli Lilly and Company’s biologic drug candidate that is in development for treating migraine.
Dec 08, 2017
By BioPharm International Editors
The new 30,000-L, $150-million biologics manufacturing facility in Wuxi, China, quintuples the company’s existing manufacturing capability.
Dec 06, 2017
By BioPharm International Editors
The company will expand two of its Ohio facilities, investing approximately $145 million to support manufacturing and warehouse operations.
Dec 06, 2017
By BioPharm International Editors
A survey by LNS Research and sponsored by Honeywell showed that industrial companies are not moving quickly to adopt cyber security; calls on CEOs to take action.
Dec 05, 2017
By BioPharm International Editors
Biopharma majors are among the industry stakeholders who have commented and raised questions about FDA’s recently proposed draft guidance for analytical assessment of similarity in biosimilars.
Dec 01, 2017
BioPharm International
Cross-functional reliability rooms identify risk and planning metrics, provide insights for production forecasts, and predict trends and areas for improvement.
Dec 01, 2017
BioPharm International
The Biomanufacturing Technology Roadmap is accelerating innovative manufacturing strategies for biopharmaceuticals.
Dec 01, 2017
BioPharm International
A quality-by-design approach that implements PAT offers advantages in upstream cell-culture processing.
Dec 01, 2017
BioPharm International
A technology roadmap aims to drive and consolidate improvements in a process that has remained unchanged for more than 70 years.
Dec 01, 2017
BioPharm International
Biopharma employees reveal employment objectives, opportunities, and frustrations.
native1_300x100
lorem ipsum